Steroids and airway mucosal vascularity in COPD patients

A. Zanini, A. Chetta, A. Tipa, R. D‘Ippolito, C. Castagnetti, A. Castagnaro, M. Neri, D. Olivieri (Tradate, Parma, Italy)

Source: Annual Congress 2005 - Cellular and molecular mechanisms in COPD
Session: Cellular and molecular mechanisms in COPD
Session type: Thematic Poster Session
Number: 686
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Zanini, A. Chetta, A. Tipa, R. D‘Ippolito, C. Castagnetti, A. Castagnaro, M. Neri, D. Olivieri (Tradate, Parma, Italy). Steroids and airway mucosal vascularity in COPD patients. Eur Respir J 2005; 26: Suppl. 49, 686

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Systemic and airway inflammation and the presence of emphysema in patients with COPD
Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment
Year: 2009


Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002

The lung microcirculation changes in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 407s
Year: 2006

Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001

Relationship between peripheral airway obstruction and airway inflammation in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 509s
Year: 2006

Airway epithelial inflammatory responses and clinical parameters in COPD
Source: Eur Respir J 2003; 22: 94-99
Year: 2003



Airway inflammation and airway pathophysiology in older asthmatics
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011

Corticosteroid increased apoptosis of airway sputum macrophages from patients with COPD and emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 337s
Year: 2001

Airway inflammation markers in COPD
Source: Annual Congress 2007 - Airway regulation, provocation and monitoring I
Year: 2007


Anti-inflammatory effect of budesonide on the central and peripheral airway inflammation in cough-variant and mild bronchial asthma
Source: Annual Congress 2008 - Comorbid cardiovascular condition and therapy of asthma
Year: 2008

Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006

Heterogeneous response of airway eosinophilia to biologics in severe asthma patients
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021


Dynamic hyperinflation contributes to systemic and airway inflammation in patients with COPD
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019


Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia
Source: Eur Respir J 2016; 47: 829-836
Year: 2016



Is lung emphysema in COPD patients reflected by central airways inflammation?
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003

Smoking and airway inflammation in asymptomatic subjects and in patients with chronic airway disease
Source: Eur Respir J 2002; 20: Suppl. 38, 90s
Year: 2002

Airway inflammation and inhaled corticosteroids in COPD
Source: Eur Respir J, 49 (6) 1700289; 10.1183/13993003.00289-2017
Year: 2017